Development of novel therapeutics for the treatment of the genetic disorder Spinal Muscular Atrophy

Development of novel therapeutics for the treatment of the genetic disorder Spinal Muscular Atrophy

Development of novel therapeutics for the treatment of the genetic disorder Spinal Muscular Atrophy


Dr. Otis Vacratsis

University of Windsor

 

tbd

Related Programs:
Nucleus Cores:

FUNDER:

Canadian Institutes of Health Research

GRANT DURATION:

2018-2020

 

Loading...